Drug Profile
Anti-ICAM-1 monoclonal antibody HA58
Alternative Names: HA58Latest Information Update: 01 Sep 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Intercellular adhesion molecule 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 01 Sep 1998 No-Development-Reported for Transplant rejection in Japan (Unknown route)
- 04 Sep 1996 New profile
- 04 Sep 1996 Preclinical development for Transplant rejection in Japan (Unknown route)